A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy
Latest Information Update: 20 May 2014
At a glance
- Drugs Interleukin-7 (Primary)
- Indications Progressive multifocal leukoencephalopathy
- Focus Therapeutic Use
- Acronyms INVICTUS
- Sponsors Revimmune SAS
- 02 Feb 2013 Planned end date changed from 1 Jun 2015 to 22 Jul 2015 as reported by European Clinical Trials Database record.
- 21 Jan 2013 New trial record